Understanding Treatment Costs When exploring ketamine therapy, patients generally encounter two distinct treatment pathways with differing financial implications. Spravato (esketamine) is an FDA-approved nasal spray for specific adult depression indications. Because it holds FDA approval, Spravato is often eligible for health insurance coverage, though policies vary significantly. Patients typically must undergo a prior authorization process to verify eligibility before proceeding.

Conversely, off-label treatments using IV, IM, or sublingual ketamine are widely considered experimental by most insurers and usually require out-of-pocket, self-pay arrangements. Patients should always request a detailed, written estimate from their chosen clinic that outlines all clinical fees, monitoring costs, and administrative charges.

Factoring in Travel and Additional Expenses Patients must also account for the hidden costs of treatment, which often include repeated travel expenses and potential lodging if the clinic is located far from home. Additionally, patients should be aware of safety advisories regarding off-label formulations. The FDA has published critical guidance regarding these off-label uses; you can read more as the FDA warns patients and health care providers about potential risks associated with compounded ketamine products. Reviewing these considerations carefully will help you make a financially and medically informed decision.

Assessment and Ongoing Treatment Accessing ketamine therapies requires a comprehensive clinical assessment. For FDA-approved options like Spravato, patients must receive the medication in a certified healthcare setting. Administration involves at least two hours of on-site clinical observation. Due to the medication's effects, patients cannot drive until the next day, following a restful sleep. A responsible adult must provide transportation home after each session. Spravato is never administered at home. Some clinicians prescribe compounded ketamine formulations off-label for home use; however, these are not FDA-approved for psychiatric care, and the FDA warns about risks without on-site monitoring. Telehealth may support initial assessments but does not guarantee home treatment availability.

Logistical and Safety Considerations Patients in Indiana must plan carefully for a multi-week treatment schedule. Winter snow and ice, severe storms, Indianapolis traffic, and rural travel distances may affect your ability to reach appointments safely. Always prepare a contingency plan for weather and traffic delays.

If you or a loved one is experiencing a mental health crisis, immediate help is available. Contact the 988 Suicide & Crisis Lifeline by calling or texting 988, available 24/7. In emergencies, dial 911.